What McDougall Scientific does

Alimentiv is a privately held, gastroenterology-focused Contract Research Organization headquartered in Toronto, Canada, that delivers end-to-end clinical trial services exclusively within the GI therapeutic area. The company's platform spans four integrated service areas: Clinical Trial Services (clinical development strategy, trial design and protocol development, project management, statistics, site management with risk-based monitoring, regulatory strategy, medical monitoring, clinical data science, medical writing, and clinical safety); Medical Imaging Solutions (central reading, CIMS endoscopy, AI-powered endoscopy, histology, and noninvasive imaging including IUS and MRE); Laboratory and Biomarker Services delivered through the AcelaBio histopathology laboratory; and Consulting Services. Alimentiv serves pharmaceutical and biotech companies developing GI therapeutics, supported by a global network of 5,000+ sites across 60+ countries, with offices in Toronto, San Diego, Amsterdam, and Bella Vista (Australia).

The company's core intellectual property rests on proprietary scoring instruments — the UC-100 Score, Robarts Histopathology Index, and SIQ-UC/SIQ-CD Patient-Reported Outcomes — that have been adopted as standardized endpoints in inflammatory bowel disease trials. Alimentiv reports supporting over 70% of IBD compounds in development and producing 200+ peer-reviewed publications in the last five years, reinforcing a data and scientific-leadership position that is difficult for generalist CROs to replicate. The revenue model is professional-services based, with quote-based engagement and direct enterprise sales to pharma and biotech sponsors; specific contract values and pricing are not publicly disclosed. Subsidiary AcelaBio extends the platform into integrated histopathology and precision medicine, and the AI-powered endoscopy solution represents an early-stage computer-vision capability layered onto the central reading workflow.

Name

McDougall Scientific

Legal name

Alimentiv Inc.

Website

https://www.mcdougallscientific.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

Alimentiv is a Toronto-based, privately held gastroenterology CRO providing end-to-end clinical trial services to pharmaceutical and biotech sponsors developing GI therapeutics, supported by proprietary endpoint scoring systems and a 5,000+ site global network across 60+ countries.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

Keywords

• Biostatistics services
• Clinical data management
• Clinical trial design
• Clinical trial reporting
• Statistical consulting

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Clinical Research Services: End-to-end CRO services for gastroenterology clinical trials including clinical development strategy, trial design, project management, statistics, site management, regulatory strategy, medical monitoring, clinical data science, medical writing, and clinical safety services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

McDougall Scientific provides specialized statistical analysis, top-tier data management, reporting, and clinical trial design services to support clinical research programs. The firm operates as a focused biostatistics and clinical research support provider.

Product overview

Alimentiv is a premier gastrointestinal CRO offering a comprehensive, integrated platform of clinical trial services. The company provides end-to-end expertise through four core service areas: Clinical Trial Services (covering strategy, operations, data science, and safety), Medical Imaging Solutions (including central reading, CIMS endoscopy solutions, AI-powered endoscopy, and histology), Laboratory & Biomarker Services (via AcelaBio), and Consulting Services. The platform is distinguished by proprietary indices including the UC-100 Score, Robarts Histopathology Index, and SIQ-UC/SIQ-CD PROs. The company leverages AI-powered endoscopy solutions and has supported over 70% of IBD compounds in development, with global access to 5,000+ sites in 60+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• CIMS: Endoscopy Solutions - Central Imaging Management System for GI clinical trials.
• AcelaBio

Products and services

• Statistical Analysis Services

Quantifiable outcome

• 20% fewer non-screening sites via data-driven selection
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

One partnership is on record.

• AcelaBiocoreStrategic or Co-development PartnerAcelaBio is Alimentiv's state-of-the-art histopathology laboratory providing end-to-end GI histopathology and precision medicine services. This partnership enables integrated histopathology services as part of Alimentiv's comprehensive GI clinical trial offerings.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-sized full-service CRO with embedded biostatistics and data management capabilities; competes for trial design and statistics work that McDougall would otherwise bid on as a niche specialist.
• ICON plc: One of the largest global CROs with deep biostatistics, statistical programming, and data management practices; provides both a substitute and a potential upstream/downstream referral channel for McDougall.
• IQVIA: Largest global CRO and life sciences services platform with a full biostatistics offering; competes at the top of the market where McDougall cannot reach but sets the benchmark for sponsor expectations.
• Worldwide Clinical Trials: Mid-to-large global CRO offering biostatistics, data management, and trial design; competes with McDougall for mid-sized biostatistics engagements and represents a realistic exit or scale-up benchmark.
• Eurofins Clinical Trial Services: Large clinical research services platform with biostatistics and data management capabilities acquired through multiple roll-ups; relevant broad incumbent competing for the same sponsor budgets.
• Parexel: Global full-service CRO with established biostatistics, statistical programming, and clinical data management practices; another incumbent reference point for sponsor expectations in trial statistics.

Direct peers

• Cytel: Specialized biostatistics and statistical programming CRO with a similarly narrow focus on clinical trial statistics, design, and SAS/R programming — the most directly comparable peer to McDougall Scientific.
• Berry Consultants: Statistical consulting firm focused on Bayesian and adaptive trial design for clinical research, competing for the same specialized biostatistics and clinical trial design spend as McDougall Scientific.
• Axio Research: Statistical and data management CRO providing biostatistics, clinical data management, and statistical programming services to pharma and biotech sponsors — a tight comparability match for McDougall's service stack.
• Rho: Full-service CRO with a strong biostatistics and clinical data management practice; comparable in service scope and mid-sized positioning, competing for similar biostatistics RFPs.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat6 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/alimentiv
• YouTubeyoutube.com/@alimentiv8700
• LinkedInlinkedin.com/company/alimentiv

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about McDougall Scientific